The function identification of hepatocyte diffirentiated from CTLA4-gene modified bone marrow mesenchymal stem cells

Progress in Biochemistry and Biophysics

Volumn 35, Issue 9, 2008, Pages 1021-1030

  Luo, Hai Ying ^a,b   Wang, Yun Fang ^a   Zhai, Shu Sen ^c   Zhang, Yu Jun ^d   Nan, Xue ^a   Bai, Ci Xian ^a   Shi, Shuang Shuang ^a   Yu, Cheng Ze ^c   Yue, Wen ^a   Kong, Wei ^b   Pei, Xue Tao ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b JILIN UNIVERSITY   (China)

^c Beijing 307 Hospital   (China)

^d THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Adenovirus; Bone marrow mesenchymal stem cells; CTLA4Ig; Differentiation; Immunosuppression

Indexed keywords

ADENOVIRIDAE; RATTUS;

EID: 57349199883     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Bruder S P, Jaiswal N, Ricalton N S, et al. Mesenchymal stem cells in osteobiology and applied bone regeneration. Clin OrthopRelat Res, 1998, 355(Suppl): S247-S256
2. Ogueta S, Munoz J, Obregon E, et al. Prolactin is a component of the human synovial liquid and modulates the growth and chondrogenic differentiation of bone marrow-derived mesenchymal stem cells. Mol Cell Endocrinol, 2002, 190(1-2): 51-63
3. Murphy J M, Dixon K, Beck S, et al. Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. Arthritis Rheum, 2002, 46(3): 704-713
4. Dezawa M, Kanno H, Hoshino M, et al. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest, 2004, 113(12): 1701-1710
5. Duan H F, Wu C T, Wu D L, et al. Treatment of myocardial ischemia with bone marrow-derived mesenchymal stem cells overexpressing hepatocyte growth factor. Mol Ther, 2003, 8(3): 467-474
6. Ong S Y, Dai H, Leong K W. Inducing hepatic differentiation of human mesenchymal stem cells in pellet culture. Biomaterials, 2006, 27(22): 4087-4097
7. Aurich I, Mueller L P, Aurich H, et al. Functional integration of human mesenchymal stem cell-derived hepatocytes into mouse livers. Gut, 2007, 56(3): 405-415
8. Sato Y, Araki H, Kato J, et al. Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood, 2005, 106(2): 756-763
9. Oyagi S, Hirose M, Kojima M, et al. Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CC14-injured rats. J Hepatol, 2006, 44(4): 742-748
10. Nicoletta E, John S, Laurence L, et al. Allogeneic marrow stromal cells are immune rejected by MHC class I-andclass II-mismatched recipient mice. Blood, 2005, 106(13): 4057-4065
11. Alma J N, Geert W, Alwine B K, et al. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloalative setting. Blood, 2006, 108(6): 2114-2120
12. June C H, Bluestone J A, Nadler L M, et al. The B7 and CD28 receptor families. Immunol Today, 1994, 15(7): 321-331
13. Kamada N, Calne R Y. A surgical experience with five hundred thirty liver transplantation in the rats. Surg, 1983, 93(1): 64-69
14. Yue Y, Ai-Hua Y, Nian C, et al. Mesenchymal stem cells over-expressing hepatocyte growth factor improve small-for-size liver grafts regeneration. The American Society of Gene Therapy, 2007, 15(7): 1382-1389
15. Wada M R, Inagawa-Ogashiwa M, Shimizu S, et al. Generation of different fates from multipotent muscle stem cells. Development, 2002, 129(12): 2987-2995
16. - differentiated human ESCs. Stem Cells, 2007, 25(2): 425-436
17. Le Blanc K, Tammik C, Rosendahl K, et al. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol, 2003, 31(10): 890-896
18. Hua L, David Michael K, Boon Chin H, et al. The immunogenicity and immunomodulatory function of osteogenic cells differentiated from mesenchymal stem cells. J Immunology, 2006, 176(5): 2864-2871
19. Sudeepta A, Mark F P. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, 2005, 105: 1815-1822
20. Xiao-Xia J, Yi Z, Bing L, et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood, 2005, 105(4): 4120-4126
21. Grazia M S, Andrea C, Stelvio B, et al. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood, 2006, 107(4): 1484-1490
22. Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol, 2002, 30(1): 42-48